These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 24083085)
1. Immunological monitoring of anticancer vaccines in clinical trials. Ogi C; Aruga A Oncoimmunology; 2013 Aug; 2(8):e26012. PubMed ID: 24083085 [TBL] [Abstract][Full Text] [Related]
2. Clinical evaluation of therapeutic cancer vaccines. Ogi C; Aruga A Hum Vaccin Immunother; 2013 May; 9(5):1049-57. PubMed ID: 23454867 [TBL] [Abstract][Full Text] [Related]
3. Sipuleucel-T: APC 8015, APC-8015, prostate cancer vaccine--Dendreon. Drugs R D; 2006; 7(3):197-201. PubMed ID: 16752945 [TBL] [Abstract][Full Text] [Related]
4. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism. Amanpour S Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952 [TBL] [Abstract][Full Text] [Related]
5. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal. Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502 [TBL] [Abstract][Full Text] [Related]
6. Cancer cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer as vaccines for the treatment of genitourinary malignancies. Nelson WG; Simons JW; Mikhak B; Chang JF; DeMarzo AM; Carducci MA; Kim M; Weber CE; Baccala AA; Goeman MA; Clift SM; Ando DG; Levitsky HI; Cohen LK; Sanda MG; Mulligan RC; Partin AW; Carter HB; Piantadosi S; Marshall FF Cancer Chemother Pharmacol; 2000; 46 Suppl():S67-72. PubMed ID: 10950151 [TBL] [Abstract][Full Text] [Related]
8. Anticancer Drug Development: The Way Forward. Connors T Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985 [TBL] [Abstract][Full Text] [Related]
9. HIV gp120 vaccine - VaxGen: AIDSVAX, AIDSVAX B/B, AIDSVAX B/E, HIV gp120 vaccine - Genentech, HIV gp120 vaccine AIDSVAX - VaxGen, HIV vaccine AIDSVAX - VaxGen. Adis International Ltd Drugs R D; 2003; 4(4):249-53. PubMed ID: 12848591 [TBL] [Abstract][Full Text] [Related]
10. Unraveling the role of preexisting immunity in prostate cancer patients vaccinated with a HER-2/neu hybrid peptide. Voutsas IF; Anastasopoulou EA; Tzonis P; Papamichail M; Perez SA; Baxevanis CN J Immunother Cancer; 2016; 4():75. PubMed ID: 27891225 [TBL] [Abstract][Full Text] [Related]
11. Assessment of Immune Response Following Dendritic Cell-Based Immunotherapy in Pediatric Patients With Relapsing Sarcoma. Fedorova L; Mudry P; Pilatova K; Selingerova I; Merhautova J; Rehak Z; Valik D; Hlavackova E; Cerna D; Faberova L; Mazanek P; Pavelka Z; Demlova R; Sterba J; Zdrazilova-Dubska L Front Oncol; 2019; 9():1169. PubMed ID: 31799177 [TBL] [Abstract][Full Text] [Related]
12. Erlotinib: CP 358774, NSC 718781, OSI 774, R 1415. Adis International Ltd Drugs R D; 2003; 4(4):243-8. PubMed ID: 12848590 [TBL] [Abstract][Full Text] [Related]
13. Current status of therapeutic vaccines for non-Hodgkin's lymphoma. Hurvitz SA; Timmerman JM Curr Opin Oncol; 2005 Sep; 17(5):432-40. PubMed ID: 16093791 [TBL] [Abstract][Full Text] [Related]
14. Cancer vaccine THERATOPE- Biomira. Adis International Ltd Drugs R D; 2003; 4(4):236-40. PubMed ID: 12848588 [TBL] [Abstract][Full Text] [Related]
15. Measurement of malaria vaccine efficacy in phase III trials: report of a WHO consultation. Moorthy V; Reed Z; Smith PG; Vaccine; 2007 Jul; 25(28):5115-23. PubMed ID: 17577487 [TBL] [Abstract][Full Text] [Related]